Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Enlight Biosciences formed with $39mm in funding

Executive Summary

Eli Lilly, Merck, Pfizer, and PureTech Ventures have teamed up to form Enlight Biosciences, contributing $39mm to the new company.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
    • Large Molecule
      • Antibodies
    • Pharmacogenetics-Pharmacogenomics
    • Synthesis Technologies, Production Processes
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Drug Delivery
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies